Use of xenon for the prevention of programmed cell death

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2542412

Described is the use of xenon for preventing or reducing cellular death, preferably aberrant apoptosis. Preferred embodiments relate to the use of xenon for preventing (a) cellular damage for tissue and organs to be transplanted, (b) apoptotic cell death after eye laser surgery, and (c) for protecting endothelial cells of the intestine in sepsis.

Cette invention concerne l'emploi du xénon pour prévenir ou réduire la mort des cellules, de préférence en cas d'apoptose aberrante. Dans des modes de réalisation préférés, on utilise le xénon pour (a) prévenir des dégâts cellulaires dans le cas de tissus ou d'organes à transplanter, (b) prévenir la mort apoptotique de cellule après chirurgie oculaire au laser, et (c) protéger les cellules endothéliales des intestins en cas de sepsis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of xenon for the prevention of programmed cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of xenon for the prevention of programmed cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xenon for the prevention of programmed cell death will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1467266

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.